A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs
For the initial phase of pandemic of coronavirus disease 2019 (COVID-19), repurposing drugs that in vitro inhibit severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have been attempted with overlooked or overestimated efficacy owing to limited clinical evidence. Most early clinical trials...
Saved in:
Main Authors: | Po-Lin Chen (Author), Nan-Yao Lee (Author), Cong-Tat Cia (Author), Wen-Chien Ko (Author), Po-Ren Hsueh (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
by: Nan-Yao Lee, et al.
Published: (2019) -
A Cohort Study of Adult Patients with Severe Dengue in Taiwanese Intensive Care Units: The Elderly and APTT Prolongation Matter for Prognosis.
by: Chih-Cheng Hsieh, et al.
Published: (2017) -
Comparing the Prognostic Impacts of Delayed Administration of Appropriate Antimicrobials in Older Patients with Afebrile and Febrile Community-Onset Bacteremia
by: Shu-Chun Hsueh, et al.
Published: (2024) -
Is Early Oral Antimicrobial Switch Useful for Less Critically Ill Adults with Community-Onset Bacteraemia in Emergency Departments?
by: Ching-Chi Lee, et al.
Published: (2020) -
Definitive Cefazolin Treatment for Community-Onset Enterobacteriaceae Bacteremia Based on the Contemporary CLSI Breakpoint: Clinical Experience of a Medical Center in Southern Taiwan
by: Ching-Chi Lee, et al.
Published: (2019)